AbbVie Rg
ABBV
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Last quote
05/08/2025 - 22:15:00
Bid
05/08/2025 - 21:59:59
Bid
Volume
Ask
05/08/2025 - 21:59:59
Ask
Volume
185.58
-2.51 ( -1.33% )
185.56
4,300
185.57
3,200
More information
Analysis by TheScreener
06.05.2025
Evaluation Neutral  
Interest Strong  
Sensibility Middle  
Analysis date: 06.05.2025
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 22.04.2025.
Interest
  Strong
Three stars since 02.05.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 15.04.2025 at a price of 176.80.
Evaluation
  Strongly undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 02.05.2025.
4wk Rel Perf
  -10.22%
 
The four-week dividend-adjusted underperformance versus SP500 is 10.22%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 28.02.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -1.23%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.74%.
Mkt Cap in $bn
  346.84
With a market capitalization >$8bn, ABBVIE is considered a large-cap stock.
G/PE Ratio
  1.47
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of .
LT P/E
  10
The estimated PE is for the year 2029.
LT Growth
  11.18%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
  17
Over the last seven weeks, an average of 17 analysts provided earnings per share estimates.
Dividend Yield
  3.56%
The twelve month estimated dividend yield represents 35.58% of earnings forecasts.
Beta
  38
For 1% of index variation, the stock varies on average by 0.38%.
Correlation
  0.24
Stock movements are strongly independent of index variations.
Value at Risk
  25.98
The value at risk is estimated at USD 25.98. The risk is therefore 13.88%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  05.04.2013